EdgarLookup

Tanke Biosciences Corp — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Tanke Biosciences Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue (Net Sales) — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2013 Sep 30, 2013 $6.04M Nov 14, 2013
Q2 2013 Jun 30, 2013 $5.58M Aug 15, 2013
Q1 2013 Mar 31, 2013 $4.66M May 20, 2013
Q3 2012 Sep 30, 2012 $9.91M Nov 14, 2012
Q2 2012 Jun 30, 2012 $7.43M Aug 27, 2012
Q1 2012 Mar 31, 2012 $4.54M May 17, 2012
Q3 2011 Sep 30, 2011 $6.25M Nov 21, 2011
Q2 2011 Jun 30, 2011 $4.99M Nov 3, 2011
Q1 2012 Mar 31, 2011 $5.94M May 17, 2012
Q3 2011 Sep 30, 2010 $5.70M Nov 21, 2011
Q2 2011 Jun 30, 2010 $4.27M Nov 3, 2011

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2013 Sep 30, 2013 ($302.1K) Nov 14, 2013
Q2 2013 Jun 30, 2013 $118.2K Aug 15, 2013
Q1 2013 Mar 31, 2013 ($676.3K) May 20, 2013
Q3 2012 Sep 30, 2012 $968.6K Nov 14, 2012
Q2 2012 Jun 30, 2012 $272.4K Aug 27, 2012
Q1 2012 Mar 31, 2012 ($671.0K) May 17, 2012
Q3 2011 Sep 30, 2011 ($1.45M) Nov 21, 2011
Q2 2011 Jun 30, 2011 ($1.65M) Nov 3, 2011
Q1 2012 Mar 31, 2011 ($2.02M) May 17, 2012
Q3 2011 Sep 30, 2010 $760.2K Nov 21, 2011
Q2 2011 Jun 30, 2010 $568.3K Nov 3, 2011

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2013 Sep 30, 2013 ($530.3K) Nov 14, 2013
Q2 2013 Jun 30, 2013 $149.7K Aug 15, 2013
Q1 2013 Mar 31, 2013 ($39.9K) May 20, 2013
Q3 2012 Sep 30, 2012 $2.18M Nov 14, 2012
Q2 2012 Jun 30, 2012 $1.50M Aug 27, 2012
Q1 2012 Mar 31, 2012 $488.5K May 17, 2012
Q3 2011 Sep 30, 2011 $1.20M Nov 21, 2011
Q2 2011 Jun 30, 2011 $229.6K Nov 3, 2011
Q1 2012 Mar 31, 2011 ($715.0K) May 17, 2012
Q3 2011 Sep 30, 2010 $1.25M Nov 21, 2011
Q2 2011 Jun 30, 2010 $917.0K Nov 3, 2011